E-ISSN 2149-388X | ISSN 2149-0430
 
2025, Vol: 11, Issue: 1
11 / 1Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

Cover Letter
License Agreement
Title Page

Original Article 


The Use of Fibrin Sealant in Chiari Malformation Type-1 Surgery; Is It Effective in Preventing the Formation of CSF Fistula?

Huseyin Dogu, Abdurrahman Avar Ozdemir.


Abstract
Background: Symptomatic disease requires surgical intervention comprising of posterior fossa decompression with or without an expansile duraplasty. Until date, the optimal surgical treatment for CM-1 has not been delineated. Thus, we evaluated the results to assess the effectiveness of fibrin sealant augmentation in combination with locally harvested autologous pericranium for duraplasty in adult CM-1 decompression.
Materials and Methods: We retrospectively evaluated the cases that were operated due to CM-1. The cases were divided into two groups in which fibrin sealant (FS) was used and not used. There were 15 patients in the first group (FS group) and 16 in the second group (no fibrin sealant (NFS) group). We followed the standardized surgical technique suggested by Stevens and colleagues for CM 1 decompression.
Results: Cerebrospinal fluid (CSF) fistula was not observed in any patient in the FS group. However, in the NFS group, two patients were reported to develop CSF fistula. Although the findings are not statistically significant, these are clinically important.
Conclusion: Use of FS to seal the autologous graft during closure may prevent the occurrence of CSF fistula among patients of CM-1.

Key words: Arnold-Chiari malformation, Type 1, fibrin sealant, autografts, cerebrospinal fluid leakage


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Huseyin Dogu
Articles by Abdurrahman Avar Ozdemir
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Dogu H, Ozdemir AA. The Use of Fibrin Sealant in Chiari Malformation Type-1 Surgery; Is It Effective in Preventing the Formation of CSF Fistula?. Ulutas Med J. 2019; 5(1): 65-70. doi:10.5455/umj.20191108075317

Web Style

Dogu H, Ozdemir AA. The Use of Fibrin Sealant in Chiari Malformation Type-1 Surgery; Is It Effective in Preventing the Formation of CSF Fistula?. https://www.ulutasmedicaljournal.com/?mno=16164 [Access: March 15, 2025]. doi:10.5455/umj.20191108075317

AMA (American Medical Association) Style

Dogu H, Ozdemir AA. The Use of Fibrin Sealant in Chiari Malformation Type-1 Surgery; Is It Effective in Preventing the Formation of CSF Fistula?. Ulutas Med J. 2019; 5(1): 65-70. doi:10.5455/umj.20191108075317


Vancouver/ICMJE Style

Dogu H, Ozdemir AA. The Use of Fibrin Sealant in Chiari Malformation Type-1 Surgery; Is It Effective in Preventing the Formation of CSF Fistula?. Ulutas Med J. (2019), [cited March 15, 2025]; 5(1): 65-70. doi:10.5455/umj.20191108075317


Harvard Style

Dogu, H. & Ozdemir, . A. A. (2019) The Use of Fibrin Sealant in Chiari Malformation Type-1 Surgery; Is It Effective in Preventing the Formation of CSF Fistula?. Ulutas Med J, 5 (1), 65-70. doi:10.5455/umj.20191108075317


Turabian Style

Dogu, Huseyin, and Abdurrahman Avar Ozdemir. 2019. The Use of Fibrin Sealant in Chiari Malformation Type-1 Surgery; Is It Effective in Preventing the Formation of CSF Fistula?. THE ULUTAS MEDICAL JOURNAL, 5 (1), 65-70. doi:10.5455/umj.20191108075317


Chicago Style

Dogu, Huseyin, and Abdurrahman Avar Ozdemir. "The Use of Fibrin Sealant in Chiari Malformation Type-1 Surgery; Is It Effective in Preventing the Formation of CSF Fistula?." THE ULUTAS MEDICAL JOURNAL 5 (2019), 65-70. doi:10.5455/umj.20191108075317


MLA (The Modern Language Association) Style

Dogu, Huseyin, and Abdurrahman Avar Ozdemir. "The Use of Fibrin Sealant in Chiari Malformation Type-1 Surgery; Is It Effective in Preventing the Formation of CSF Fistula?." THE ULUTAS MEDICAL JOURNAL 5.1 (2019), 65-70. Print. doi:10.5455/umj.20191108075317


APA (American Psychological Association) Style

Dogu, H. & Ozdemir, . A. A. (2019) The Use of Fibrin Sealant in Chiari Malformation Type-1 Surgery; Is It Effective in Preventing the Formation of CSF Fistula?. THE ULUTAS MEDICAL JOURNAL, 5 (1), 65-70. doi:10.5455/umj.20191108075317


Author LoginReviewer LoginAbout PublisherOpen Access PolicyEditorial PoliciesEditorial Review PolicyPeer Review PolicyEditorial & Peer Review ProcessAuthor's Rights and ObligationsPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPlagiarism PolicyProtection of Research Participants (Statement On Human And Animal Rights)Privacy PolicyCorrections, Retractions & Expressions of ConcernSelf-Archiving PoliciesDigital Archiving & Preservation PoliciesStatement of Informed ConsentAdvertising PolicyTerms of UseLicense InformationCopyright Information

About THE ULUTAS MEDICAL JOURNAL

The Ulutas Medical Journal (UMJ) is a 3 monthly (quarterly), open access, double-blind peer-reviewed, an international journal. Writing a research pap ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information


Journal Owner
HAYRİYE ZEHRA ULUTAŞ
Phone: +90 (532) 165 96 39​
E-mail: zehrakenanoglu@hotmail.com​
Address: Alaattin Mah. 30. Ada sok. D11 Blok
No:4 Gungor Uydukent Sitesi  Antakya/HATAY

Editor-In-Chief
KEMAL TURKER ULUTAS, MD, Assc. Prof.
Phone: + 90 (555) 491 35 59​
E-mail: drkemalturker@gmail.com
Address: Alaattin Mah. 30. Ada sok. D11 Blok
No:4 Gungor Uydukent Sitesi  Antakya/HATAY

Publisher Information
SCOPEMED Publishing Co. - TURKEY​
E-mail: scopemed@scopemed.org
Web: https://www.scopemed.com/

 

We welcome your submissions, suggestions, comments, or questions. To reach us, please use one of the methods provided on this page or Email us at ulutasmedicaljournal@gmail.com​

We will respond within 48 to 72 hours.